This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Dingjiang Liu, PhD
Director, Formulation Development at Regeneron Pharmaceuticals


Dingjiang (Dean) Liu, Ph.D. is currently Director in Formulation Development Group at Regeneron Pharmaceuticals Inc. (Tarrytown, NY).

Dean graduated from Fudan University with a BS degree in Chemistry; then from University of Wisconsin-Milwaukee with a Ph.D in Chemistry and Biochemistry.

Dean worked at Schering Plough Research Institute (now Merck Co.) and Amgen prior to join Regeneron. His current work is focused on the development of formulation, drug product process, and analytical method and new technologies for a wide range of biological drug products with emphasis on applying Qbd approaches to the drug product development from research to commercialization.  He has extensive experience with analytical and biophysical methods to study developability and shelf life stability of protein therapeutics and application of protein engineering approaches to improve the protein drug development. He has authored/co-authored more than 40 scientific papers and patents.